Status:

UNKNOWN

Comprehensive Assessment of Neurodegeneration and Dementia

Lead Sponsor:

McGill University

Collaborating Sponsors:

Canadian Institutes of Health Research (CIHR)

Alzheimer Society of Canada

Conditions:

Dementia

Eligibility:

All Genders

50-90 years

Brief Summary

This is a 5-year observational study recruiting sixteen hundred and fifty individuals between the ages of 50 and 90 with different types of dementia as well as a comparison group of six hundred and fi...

Detailed Description

This is a 5-year observational study. Sixteen-hundred and fifty (1650) subjects, between the ages of 50 and 90,years old, with Subjective Cognitive Impairment, Mild Cognitive Impairment, Mild Cognitiv...

Eligibility Criteria

Inclusion

  • Has subjective or objective cognitive impairment
  • Written informed consent must be obtained and documented (from the patient or, where jurisdictions allow it, from a caregiver/family member)
  • Sufficient proficiency in English or French to undertake self report and neuropsychological testing
  • Geographic accessibility to the study site
  • Must have a study partner who can participate as required in the protocol (provide corroborative information)

Exclusion

  • The presence of other significant known chronic brain disease such as: moderate to severe chronic static leukoencephalopathy (including previous traumatic injury), multiple sclerosis, a serious developmental handicap, malignant tumors, Parkinson's disease (other than for the Parkinson's/Lewy Body Dementia cohort), and other rarer brain illnesses
  • Ongoing alcohol or drug abuse which in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures
  • Symptomatic stroke within the previous year
  • MoCA \< 13
  • Unable to undergo MRI scan due to medical contraindications or inability to tolerate the procedure

Key Trial Info

Start Date :

June 1 2016

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 1 2023

Estimated Enrollment :

2300 Patients enrolled

Trial Details

Trial ID

NCT03402919

Start Date

June 1 2016

End Date

September 1 2023

Last Update

October 4 2019

Active Locations (29)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 8 (29 locations)

1

Foothills Medical Centre

Calgary, Alberta, Canada, T2N 2T9

2

University of Alberta Hospital

Edmonton, Alberta, Canada, T6G 2B7

3

University of Northern British Columbia

Prince George, British Columbia, Canada, V2N 4Z9

4

Vancouver Coastal Health Research Institute

Vancouver, British Columbia, Canada, V5Z 1M9